One of the reasons for the failure of potential anticancer drugs in clinical trials is the imperfection of existing preclinical screening systems. Perhaps the most important step is in vitro testing during which several substances with certain properties should be selected from a large number of substances. An effective system of screening should closely resemble the organization of naturally occurring tumors. Cell cultures are the most simple from technical point of view in vitro models of tumors. However, in many respects cell cultures different from natural tumors. Several models which are more accurately (compared to simple monolayer cultures) emulate the tumor and its microenvironment are developed. An example is three-dimensional cult...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
The development of new high-tech systems for screening anticancer drugs is one of the main problems ...
One of the reasons for the failure of potential anticancer drugs in clinical trials is the imperfect...
One of the reasons for the failure of potential anticancer drugs in clinical trials is the imperfect...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
© Copyright © 2020 Kitaeva, Rutland, Rizvanov and Solovyeva. The development of new high-tech system...
Preclinical screening of medicinal drugs for novel anti-cancer treatments faces a problem of a ratio...
Three-dimensional (3D) cultures are becoming increasingly popular due to their ability to mimic tiss...
The study of the development of anti-cancer drugs and preclinical efficacy tests has until today enc...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
Today, innovative three-dimensional (3D) cell culture models have been proposed as viable and biomim...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
The development of new high-tech systems for screening anticancer drugs is one of the main problems ...
One of the reasons for the failure of potential anticancer drugs in clinical trials is the imperfect...
One of the reasons for the failure of potential anticancer drugs in clinical trials is the imperfect...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
A primary reason why potential anticancer drugs fail in clinical trials is the limitations of existi...
© Copyright © 2020 Kitaeva, Rutland, Rizvanov and Solovyeva. The development of new high-tech system...
Preclinical screening of medicinal drugs for novel anti-cancer treatments faces a problem of a ratio...
Three-dimensional (3D) cultures are becoming increasingly popular due to their ability to mimic tiss...
The study of the development of anti-cancer drugs and preclinical efficacy tests has until today enc...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
Today, innovative three-dimensional (3D) cell culture models have been proposed as viable and biomim...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
International audienceCancer is a multifactorial disease that is responsible for 10 million deaths p...
The development of new high-tech systems for screening anticancer drugs is one of the main problems ...